作者：
Fink,A.M. [1]
;
B?ttcher,S. [2]
;
Ritgen,M. [3]
;
Fischer,K. [4]
;
Pflug,N. [5]
;
Eichhorst,B. [6]
;
Wendtner,C.-M. [7]
;
Winkler,D. [8]
;
Bühler,A. [9]
;
Zenz,T. [10]
;
Staib,P. ;
Mayer,J. ;
Hensel,M. ;
Hopfinger,G. ;
Wenger,M. ;
Fingerle-Rowson,G. ;
D?hner,H. ;
Kneba,M. ;
Stilgenbauer,S. ;
Busch,R. ;
Hallek,M.
作者单位：
Second Department of Medicine, University Hospital of Schleswig-Holstein, Campus Kiel, Kiel, Germany
[1]
Klinik für H?matologie und Onkologie, St. Antonius Hospital Eschweiler, Eschweiler, Germany
[2]
Department of Medicine III, Hanusch Hospital Vienna, Vienna, Austria, 3rd Medical Department with
[3]
Institute for Medical Statistics and Epidemiology, Technical University, Munich, Germany
[4]
Department of Internal Medicine III, University of Ulm, Ulm, Germany
[5]
Pharmaceutical Division/Global Drug Dev., F. Hoffmann-La Roche Ltd., Basel, Switzerland
[6]
Department i of Internal Medicine, Center of Integrated Oncology Cologne Bonn, Cologne, Germany
[7]
Department of Internal Medicine III, University of Ulm, Ulm, Germany, Department of Translational
[8]
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Masaryk
[9]
Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer
[10]
发布时间
2013-11-20
换一批
